Patents by Inventor Donna Wei

Donna Wei has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tubulysin analogs and methods of making and use
    Patent number: 10077287
    Abstract: Tubulysin analogs of the formula (I) where R1, R2 R3, R4, R5, R6, R7, and Y are as defined herein, are anti-mitotic agents that can be used in the treatment of cancer, especially when conjugated to a targeting moiety.
    Type: Grant
    Filed: August 24, 2015
    Date of Patent: September 18, 2018
    Assignee: Bristol-Myers Squibb Company
    Inventors: Heidi L. Perez, Donna Wei, Robert M. Borzilleri, Sanjeev Gangwar, Gretchen M. Schroeder, Heng Cheng, Robert J. Schmidt
  • TUBULYSIN ANALOGS AND METHODS OF MAKING AND USE
    Publication number: 20160130299
    Abstract: Tubulysin analogs of the formula (I) where R1, R2 R3, R4, R5, R6, R7, and Y are as defined herein, are anti-mitotic agents that can be used in the treatment of cancer, especially when conjugated to a targeting moiety.
    Type: Application
    Filed: August 24, 2015
    Publication date: May 12, 2016
    Inventors: Heidi L. PEREZ, Donna WEI, Robert M. BORZILLERI, Sanjeev GANGWAR, Gretchen M. SCHROEDER, Heng CHENG, Robert J. SCHMIDT
  • Met kinase inhibitors
    Publication number: 20070117802
    Abstract: The invention is directed to compounds that are useful for the treatment of cancer having the following Formula:
    Type: Application
    Filed: September 14, 2006
    Publication date: May 24, 2007
    Inventors: Robert Borzilleri, Zhen-wei Cai, Donna Wei, John Tokarski
  • Pyrrolotriazine kinase inhibitors
    Publication number: 20060009454
    Abstract: The present invention provides compounds of formula I, and pharmaceutically acceptable salts thereof. The formula I compounds inhibit the tyrosine kinase activity of growth factor receptors such as VEGFR-2 and FGFR-1, thereby making them useful as anti-cancer agents. The formula I compounds are also useful for the treatment of other diseases associated with signal transduction pathways operating through growth factor receptors.
    Type: Application
    Filed: June 14, 2005
    Publication date: January 12, 2006
    Inventors: Zhen-wei Cai, Louis Lombardo, Rajeev Bhide, Ligang Qian, Donna Wei, Stephanie Barbosa